/
/
/

Jenburkt Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹36 Cr₹45 Cr₹43 Cr₹46 Cr₹36 Cr₹41 Cr₹37 Cr₹41 Cr₹33 Cr₹39 Cr₹36 Cr₹38 Cr₹29 Cr₹35 Cr₹35 Cr₹36 Cr₹31 Cr₹28 Cr₹33 Cr₹36 Cr₹27 Cr₹30 Cr₹32 Cr₹30 Cr₹17 Cr₹30 Cr₹34 Cr₹34 Cr₹21 Cr₹35 Cr₹32 Cr₹32 Cr₹23 Cr₹30 Cr₹31 Cr₹37 Cr₹17 Cr₹27 Cr₹25 Cr₹29 Cr₹22 Cr₹22 Cr₹24 Cr₹25 Cr₹22 Cr₹22 Cr₹21 Cr₹22 Cr₹19 Cr₹20 Cr₹19 Cr₹20 Cr₹17 Cr₹17 Cr₹18 Cr₹20 Cr
₹2 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹98 L₹1 Cr₹83 L₹86 L₹1 Cr₹93 L₹67 L₹91 L₹91 L₹65 L₹69 L₹94 L₹1 Cr₹89 L₹66 L₹63 L₹73 L₹88 L₹67 L₹60 L₹59 L₹2 Cr₹18 L₹24 L₹6 L₹74 L₹52 L₹37 L₹1 L₹56 L₹37 L₹12 L
₹37 Cr₹49 Cr₹45 Cr₹48 Cr₹38 Cr₹43 Cr₹38 Cr₹43 Cr₹34 Cr₹40 Cr₹37 Cr₹39 Cr₹30 Cr₹36 Cr₹36 Cr₹37 Cr₹32 Cr₹30 Cr₹34 Cr₹37 Cr₹28 Cr₹31 Cr₹33 Cr₹32 Cr₹18 Cr₹32 Cr₹34 Cr₹35 Cr₹22 Cr₹36 Cr₹33 Cr₹33 Cr₹24 Cr₹31 Cr₹32 Cr₹38 Cr₹18 Cr₹28 Cr₹26 Cr₹29 Cr₹23 Cr₹23 Cr₹25 Cr₹26 Cr₹23 Cr₹24 Cr₹22 Cr₹22 Cr₹19 Cr₹21 Cr₹20 Cr₹20 Cr₹17 Cr₹18 Cr₹18 Cr₹20 Cr
₹30 Cr₹31 Cr₹36 Cr₹33 Cr₹27 Cr₹31 Cr₹29 Cr₹30 Cr₹24 Cr₹30 Cr₹29 Cr₹30 Cr₹23 Cr₹28 Cr₹28 Cr₹28 Cr₹24 Cr₹24 Cr₹27 Cr₹26 Cr₹22 Cr₹25 Cr₹25 Cr₹24 Cr₹17 Cr₹25 Cr₹28 Cr₹27 Cr₹22 Cr₹27 Cr₹26 Cr₹25 Cr₹21 Cr₹22 Cr₹25 Cr₹25 Cr₹21 Cr₹22 Cr₹21 Cr₹22 Cr₹20 Cr₹20 Cr₹20 Cr₹20 Cr₹19 Cr₹19 Cr₹18 Cr₹18 Cr₹17 Cr₹18 Cr₹17 Cr₹17 Cr₹15 Cr₹15 Cr₹16 Cr₹16 Cr
₹8 Cr₹19 Cr₹9 Cr₹15 Cr₹11 Cr₹13 Cr₹10 Cr₹13 Cr₹11 Cr₹11 Cr₹9 Cr₹10 Cr₹8 Cr₹9 Cr₹8 Cr₹10 Cr₹8 Cr₹6 Cr₹8 Cr₹11 Cr₹7 Cr₹6 Cr₹8 Cr₹8 Cr₹2 Cr₹8 Cr₹7 Cr₹8 Cr₹62 L₹10 Cr₹7 Cr₹8 Cr₹4 Cr₹9 Cr₹7 Cr₹13 Cr-₹2 Cr₹7 Cr₹5 Cr₹8 Cr₹3 Cr₹4 Cr₹6 Cr₹6 Cr₹4 Cr₹6 Cr₹4 Cr₹5 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹2 Cr₹3 Cr₹2 Cr₹4 Cr
₹13 L₹13 L₹12 L₹11 L₹11 L₹11 L₹11 L₹12 L₹12 L₹6 L₹7 L₹7 L₹7 L₹8 L₹10 L₹9 L₹9 L₹12 L₹10 L₹11 L₹10 L₹12 L₹12 L₹12 L₹11 L₹12 L₹14 L₹19 L₹7 L₹10 L₹11 L₹9 L₹9 L₹13 L₹11 L₹9 L₹9 L₹13 L₹9 L₹11 L₹9 L₹12 L₹8 L₹7 L₹10 L₹9 L₹10 L₹5 L₹12 L₹0₹58 L₹21 L₹50 L₹36 L₹8 L₹26 L
₹7 Cr₹14 Cr₹8 Cr₹14 Cr₹10 Cr₹12 Cr₹10 Cr₹13 Cr₹10 Cr₹10 Cr₹8 Cr₹10 Cr₹7 Cr₹8 Cr₹8 Cr₹9 Cr₹8 Cr₹5 Cr₹8 Cr₹11 Cr₹6 Cr₹6 Cr₹7 Cr₹8 Cr₹100 L₹7 Cr₹7 Cr₹8 Cr₹2 L₹9 Cr₹7 Cr₹8 Cr₹3 Cr₹9 Cr₹7 Cr₹13 Cr-₹3 Cr₹6 Cr₹4 Cr₹7 Cr₹3 Cr₹3 Cr₹5 Cr₹5 Cr₹4 Cr₹5 Cr₹4 Cr₹4 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹1 Cr₹2 Cr₹2 Cr₹3 Cr
₹6 Cr₹11 Cr₹6 Cr₹10 Cr₹8 Cr₹9 Cr₹7 Cr₹10 Cr₹7 Cr₹8 Cr₹5 Cr₹7 Cr₹5 Cr₹6 Cr₹5 Cr₹7 Cr₹6 Cr₹3 Cr₹6 Cr₹8 Cr₹5 Cr₹4 Cr₹6 Cr₹6 Cr₹1 Cr₹5 Cr₹5 Cr₹6 Cr₹6 L₹7 Cr₹4 Cr₹6 Cr₹3 Cr₹6 Cr₹5 Cr₹10 Cr-₹3 Cr₹4 Cr₹3 Cr₹5 Cr₹2 Cr₹1 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹94 L₹2 Cr₹1 Cr₹2 Cr

Share Price Live Stats

Open (₹)1,022.60
Volume (₹)151.00
High (₹)1,037.80
Upper Circuit1,248.05
Low (₹)1,022.60
Lower Circuit832.05
Prev Close1,040.05
52W High (₹)1,321.00
Price1,037.80
52W Low (₹)944.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)459.00 Cr
Div. Yield (%)1.99
PE Ratio13.98
Debt to Equity0.00
Price to Book2.14
Book Value446.47
EPS (TTM)74.39
Face Value10.00
ROE (%)18.84

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
JENBURPH-BNSE
LTP
1W Low
1W High
Market cap (₹)
1906.25-13.85 (-0.72%)
1901
1964.85
4,56,833Cr
9217.75-51.25 (-0.55%)
9051.85
9296
2,45,426Cr
4894.2-140.8 (-2.80%)
4884.05
5049
1,87,320Cr
1132.95-54.05 (-4.55%)
1126
1191.45
1,13,217Cr
1391.5-26.5 (-1.87%)
1377
1426.20
1,12,212Cr
1854-81.3 (-4.20%)
1812
1947.90
1,01,155Cr
2124-51 (-2.34%)
2117.80
2209
97,626Cr
2351.75-35.65 (-1.49%)
2323.15
2407.40
96,859Cr
1165-12.8 (-1.09%)
1155
1179.90
96,406Cr
1657.2+7.2 (0.44%)
1623.05
1706.70
93,614Cr
1037.8-15.2 (-1.44%)
1022.60
1088.95
459Cr

Key Highlights of Jenburkt Pharmaceuticals Ltd’s P&L

In 2026-03-31, Jenburkt Pharmaceuticals Ltd reported total revenue of ₹168.74Cr, compared with ₹151.69Cr in 2025-03-31, reflecting Jenburkt Pharmaceuticals Ltd turnover.

Depreciation was ₹3.11Cr and finance costs were ₹46.2Lakh in 2026-03-31

Profit Before Tax (PBT) has been ₹46.52Cr in 2026-03-31 as compared to ₹43.93Cr in 2025-03-31.

Net Profit (PAT) was ₹34.74Cr in 2026-03-31 compared with ₹32.06Cr in 2025-03-31.

Earnings per share (EPS) were ₹78.71 in 2026-03-31, compared with ₹72.65 in 2025-03-31.